Cases & Deals

Baxter Ventures invests in Precision BioSciences

Clients Baxter International Inc.

Jones Day represented Baxter Ventures in connection with its purchase of Series A Convertible Preferred Stock in a $25.6 million private placement by Precision BioSciences, a genome editing company. Co-investors included venBio, Fidelity Biosciences, Amgen Ventures, Osage University Partners, the Longevity Fund, and two well-known public market investors.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.